A2 Milk (ASX:A2M): New Formula For Success

Marc Kennis Marc Kennis, January 15, 2022

Got milk? Why we are getting bullish on A2 Milk

 

The dogs of the ASX in 2021 had several names you can instantly think of – Nuix, Crown, AGL and perhaps – the worst of them all – A2 Milk (ASX:A2M).

The company is the subject of two class action claims over its consistent downgrades in earnings. In late October during an investor day, Chief executive David Bortolussi outlined his new plan to overhaul its China strategy, which meant operating margins will be sacrificed for revenue growth.

 

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips on the top Stocks in ASX

More recently, chairman David Hearn responded to shareholders’ concerns by saying the various updates were based on “the best information we had at the time.”

Enter Stuart Roberts from Stocks Down Under who says the worst days are behind us. Why? Listen in for his reasoning.

 

Disclosure: Stocks Down Under directors own shares in A2M.

 

A2 Milk

Stocks Down Under’s Stuart Roberts talks about A2 Milk on AusBiz

 

Want to stay up-to-date on ASX-listed stocks?
Make sure you subscribe to Stocks Down Under today!

Get a 14-day FREE TRIAL to CONCIERGE now

 

No credit card needed and the trial expires automatically.

 

Frequently Asked Questions about A2 Milk

  • Is A2 Milk an Australian company?

    No, A2M was founded in New Zealand, but has its primary stock market listing on the Australian ASX. It also operates a number of farms in Australia.

  • What is so special about a2 milk?

    A2 milk only contains the A2 beta-casein protein, not the A1 protein. A1 milk can potentially negatively affect the immunohormonal system and contribute to type 1 diabetes or heart disease. So, A2 milk is healthier for you.

  • Does A2M pay a dividend?

    No, A2M does not pay a dividend, but instead reinvests funds in the growth of its business.

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…